Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-02

Clinical Trial Update: Studio TIARA: Alessitimia ed Emicrania Cronica

View source ↗

Summary

The TIARA study investigating alexithymia and chronic migraine is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Azienda Sanitaria Locale di Alessandria | Conditions: Migraine, Alexithymia | Status: ENROLLING_BY_INVITATION